Peak Pharmaceuticals, Inc.

Peak Pharmaceuticals, Inc.

PKPH
Peak Pharmaceuticals, Inc.US flagOther OTC
1.55
USD
- -
- -
607,316.00Market Cap

Peak Pharmaceuticals, Inc. (PKPH) Stock Splits

Learn about Peak Pharmaceuticals, Inc.'s most recent 1-for-200 basis stock split on February 15, 2023. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Peak Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2023-02-15
Split Ratio: 1:200
Price Before Split: $0.04
Price After Split: $0.00

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 200.00 times fewer shares (a 1:200 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Peak Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-02-151:200Yes$0.04$0.00
2014-04-013:2No$93000.00$62000.00
2012-09-2750:1NoN/AN/A

About Peak Pharmaceuticals, Inc.

Company overview and industry information

Peak Pharmaceuticals, Inc. (PKPH) operates in the Shell Companies industry. The recent 1-for-200 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Shell Companies
Go to Peak Pharmaceuticals, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.